Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.

Our findings demonstrate the potential utility of OVP in reducing the risk of recurrent CDI in patients who require systemic antimicrobial therapy
If you want to change selection, open document below and click on "Move attachment"


owner: patientownmed - (no access) - Clin Infect Dis.-2016-Van Hise-651-3.pdf, p2


statusnot read reprioritisations
last reprioritisation on suggested re-reading day
started reading on finished reading on



Do you want to join discussion? Click here to log in or create user.